# Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism

> **NCT00920829** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 358 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Naltrexone 50 Mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00920829
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2018-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920829, "Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00920829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*